General Information of Drug (ID: DM5XX06)

Drug Name
CT-041
Indication
Disease Entry ICD 11 Status REF
Gastric cancer 2B72 Phase 1/2 [1]
Drug Type
CAR-T cell therapy
Cross-matching ID
TTD ID
DJ6AW5

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Claudin-18 (CLDN18) TT6PKBX CLD18_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04404595) Open-label, Multicenter, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous Anti-claudin 18.2 Chimeric Antigen Receptor T-cell Therapy in Subjects With Advanced Gastric, Pancreatic, or Other Specified Digestive System Cancers. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of CARSGEN